pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3915 |
Genomic Coordinates | chrX: 32583656 - 32583752 |
Description | Homo sapiens miR-3915 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3915 | |||||||||||||||
Sequence | 21| UUGAGGAAAAGAUGGUCUUAUU |42 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TMEM30B | ||||||||||||||||||||
Synonyms | CDC50B | ||||||||||||||||||||
Description | transmembrane protein 30B | ||||||||||||||||||||
Transcript | NM_001017970 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TMEM30B | |||||||||||||||||||||
3'UTR of TMEM30B (miRNA target sites are highlighted) |
>TMEM30B|NM_001017970|3'UTR 1 TTCCGGCTTTCCAGGGATCCCTCCTGCTTCTTGCCAAAACTCTTGCAAGGTGCTTTTGGCATCTCCTCCTCGCCCGTCAC 81 CCAATTCCAACCTCGCCTAGCTTTTCCTCCCTTTGTGAATGAGGGGACCAGATAAGGGAATTACCCCCCTTGCTCTTGGG 161 GGGCTGCTAGACTGTCTTGCCGCGGGGAGGGATGTTGACTGCAGAGTGAAACATCCTTGCAAACTCTTCCCACCTCCTTC 241 ACGACACTGAGTTGCCATGTGAGGTTCTTCAAGTCTGAGAGTGGAAGGGATCCCTATGGAGACTCCTATTAAACCCCTAT 321 TAGAGGAAGAGATTGAGAGACCTAGCAATGTGAAGTAACAAAGATCAGGCAGCTGCAAGTGACTCCTGAATCTTGAGTCC 401 AGGGCTTTCGCCACTACAGTACAGTGGTTTTCTTTTCTTTGGTCGGGGAGAGTGGGCTGGAATGGAGAGTGAGGCCCACA 481 AATTACCTGCAGAGACGTGGAGGCGTGAGGGAGAACATGCTTGTTAAATATGCAGGTAGATTAGGAGACACCAAACAGAG 561 ATTCAGACACAGTAAGGCTGGGATGAGATCCTCGAAGCTGTGTTTTAACAAACTCCACTGGAGAGTCCCATATTCCCTCA 641 AATTTGGGAATCACGACCCTGAACCAGGTTGGGCCTGAAGCAGTCAACTGAATTCACTTTTTCGGATAGTAATTTGTTCC 721 CAGGGGCAGTGACAACCATGATGTTCCAGGTTTGGTCTGGCACTCTGCCTTGAACGTAGGAAGCTCTTGATGATTTGTGG 801 AATGAATTTTTAAAAAATTACTATCTGGGGAAAACTAGTTGGCATACAGAGTTGTAGGACAGGGTTTATGTGATTCATTT 881 GATATTTTAGTATTTTGGTGTAAAAGCCAACAGGCAAACTTTGCCAGGTACTGTGTAGAAACTCGAAAATGTGAGGCCAG 961 TTTGTACAGTTCAGAGGAAATGCTTTAACGTAGAATCAGATAGCTGGAAGAGATCTTCGAGGGAAAGTAAGTTCCCTAAA 1041 GTCACATCTATGTCTCCTAGCTCAGTGTTCTTTGTCATTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGATTA 1121 GAAAGGGCTTCATTCATACCTTTTCCCTTGGACCTGGAAAAAAAATTTTTTTTATCTTTTCAAATGAAATCTATTGATTT 1201 CTAGTAATCATATTTGAATCAATGTTAAAGCATATATAGTCTTATATGTAAACTAGATTCTTAAGATTATTTGAACCTTT 1281 GAGATGAAGTTTACACTCAACTAAAATCATTCCATTGATTTTATTGATTAACATCAATCAGTATGTTTAAAGTTATTCTA 1361 AGAAGCAATAGTTTATTTTTAAAAACCTTGTATAGCAAAATAACTTAAAACCCTTTGTGATATCATCTTACCAGTTTATT 1441 TGGTAAAAACAAACAGTTATTTGGTATTTGTCAGAATTCTTCAGTGCCTGCTATTACAGCTATTTTCCAATTACTAACTT 1521 GATTATACTCACTCAAGGCAGTGCAAGATCTTGAAGTACTTTTTAGCAGTTAAGTAATATTGAATTGTATTGAATAGTTT 1601 ACATAGTTTATTCTAGTCTTTGAAAATTACTGAACATGGACAATGTGCATGTCATTGACATCTGCCTTAGAACTTCTGGG 1681 ACAATCCTGATTCGAGAGATTCTATCCCATTATTTACATATACCAAAAATACTTTGTTAATTTAATGTGTTGGCTTCCCA 1761 ACTCCTGAACACGACACAATTTTATTATTAGATTTTGTATGGTGATTTTAGGCTATGAAAACATGATCATTATATGTATA 1841 TAGATACATTTTTATTTGTTACAAATGTTTGAGCAGCTCACTAGCCCACCCCTCCTCTATTTTGGGTAAGAGAATTTACT 1921 ACCTTTTTTAACTATGTAGTTGAGAGCAACATGTATTTTGTTATTTTTAGAATGGTCAGTATATTGCTATAAAATTTTAA 2001 ATGAGACTATGAAAGTTAAAGTATTCTGATTCTGGTTAAATTAACGAATATGGTTCCAGGCCCTGTTCTCTGGGTTTTTG 2081 AGAGAGAATAAAGGTTATGTTTGTCTTACCTTTGTTATCGAGTTTGCTGAATTCTTTTGAACGATGATCTTAAAGGCACA 2161 AACACCACCAGCCACTTTGCTAATTTCTTAATAGCAGATTTACATTGCAGCAAGAAAACCATCTTTTATAGTAACATTCA 2241 GTTAAAATGAACTCAATTCATTGTTAACTTCCTAAAACAGAATTTGAACTTTATCAACCTCAACGTGTATATAAACTAGA 2321 TAGTCCTCAATACTTTATCAACCTCAACATGTATATAAACTAGATAGTCCTCAAATACTGTTTGAATTTAATAAATGTCA 2401 ATTTAAAAATTTTTGTAGTAGTCTTCTGCATTTTACTTCAATTATAAATTGCAATTATTTATTGGATATTTTGGACTTCA 2481 AAGCAGCAGAAACTTTAAAACTGAAATGGGAAACGTTTTCCTGCAATGATCCCTGTGCTGTAACATTTTGTCTGGTGTCT 2561 CAGGCTTCCAGGTTCTTGTTGGCCTGAATTCCCTTGTTGCCCAGTAAATGTTCACTAGCTAGAAGTATCTTCAGGAAGTG 2641 AGATAGAAAAGAGTGAACCTCAACAATTGGACTGGAAATGAGCTTTGACCTAACTTTGTAAAATAAAAGCATAAAAGAGA 2721 AA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000555868.1 | 3UTR | UCCUCAAUACUUUAUCAACCUCAACAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
111 hsa-miR-3915 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT059544 | PIP5K1A | phosphatidylinositol-4-phosphate 5-kinase type 1 alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT081703 | ZNF507 | zinc finger protein 507 | ![]() |
![]() |
2 | 2 | ||||||
MIRT083311 | ZCCHC3 | zinc finger CCHC-type containing 3 | ![]() |
![]() |
2 | 6 | ||||||
MIRT119046 | SFT2D3 | SFT2 domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT189381 | TXLNA | taxilin alpha | ![]() |
![]() |
2 | 4 | ||||||
MIRT195895 | C16ORF72 | chromosome 16 open reading frame 72 | ![]() |
![]() |
2 | 6 | ||||||
MIRT223807 | OXR1 | oxidation resistance 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT292954 | ZNF146 | zinc finger protein 146 | ![]() |
![]() |
2 | 4 | ||||||
MIRT293949 | RPL13A | ribosomal protein L13a | ![]() |
![]() |
2 | 6 | ||||||
MIRT300900 | KREMEN1 | kringle containing transmembrane protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT339332 | SESN2 | sestrin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT349304 | ZNF317 | zinc finger protein 317 | ![]() |
![]() |
2 | 2 | ||||||
MIRT364736 | TOR1B | torsin family 1 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT366233 | VMA21 | VMA21, vacuolar ATPase assembly factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT384605 | CLIC4 | chloride intracellular channel 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT401745 | HLA-DRA | major histocompatibility complex, class II, DR alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT443169 | UBL3 | ubiquitin like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT444215 | METTL12 | methyltransferase like 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT444375 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445340 | TCEANC | transcription elongation factor A N-terminal and central domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT445474 | KDM6A | lysine demethylase 6A | ![]() |
![]() |
2 | 2 | ||||||
MIRT445598 | CAMK2N1 | calcium/calmodulin dependent protein kinase II inhibitor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445630 | TMEM50A | transmembrane protein 50A | ![]() |
![]() |
2 | 2 | ||||||
MIRT446012 | VNN1 | vanin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446115 | ASTN1 | astrotactin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446248 | ELP2 | elongator acetyltransferase complex subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446382 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT446940 | ZMAT3 | zinc finger matrin-type 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446967 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447178 | PGRMC2 | progesterone receptor membrane component 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447209 | APBB2 | amyloid beta precursor protein binding family B member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447237 | IHH | indian hedgehog | ![]() |
![]() |
2 | 2 | ||||||
MIRT447807 | EMX1 | empty spiracles homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447853 | RRP8 | ribosomal RNA processing 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT448054 | MMP15 | matrix metallopeptidase 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448094 | RASD2 | RASD family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448704 | KLHL11 | kelch like family member 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448851 | FEM1C | fem-1 homolog C | ![]() |
![]() |
2 | 2 | ||||||
MIRT449488 | ZBTB4 | zinc finger and BTB domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449785 | C1orf109 | chromosome 1 open reading frame 109 | ![]() |
![]() |
2 | 2 | ||||||
MIRT450774 | PDE3A | phosphodiesterase 3A | ![]() |
![]() |
2 | 2 | ||||||
MIRT451124 | ZNF99 | zinc finger protein 99 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452676 | GPR156 | G protein-coupled receptor 156 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452888 | PSD4 | pleckstrin and Sec7 domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453188 | ACSF2 | acyl-CoA synthetase family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453353 | ZNF3 | zinc finger protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454502 | ZFYVE27 | zinc finger FYVE-type containing 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454629 | FAM83H | family with sequence similarity 83 member H | ![]() |
![]() |
2 | 2 | ||||||
MIRT455183 | AGTRAP | angiotensin II receptor associated protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT458204 | FOXL2 | forkhead box L2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458723 | CES2 | carboxylesterase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458942 | SAMD4B | sterile alpha motif domain containing 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT460304 | FLCN | folliculin | ![]() |
![]() |
2 | 2 | ||||||
MIRT460989 | SYT7 | synaptotagmin 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT461697 | ZNF426 | zinc finger protein 426 | ![]() |
![]() |
2 | 2 | ||||||
MIRT461903 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462193 | NDUFS1 | NADH:ubiquinone oxidoreductase core subunit S1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462290 | PPM1H | protein phosphatase, Mg2+/Mn2+ dependent 1H | ![]() |
![]() |
2 | 2 | ||||||
MIRT463795 | XPOT | exportin for tRNA | ![]() |
![]() |
2 | 2 | ||||||
MIRT464649 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT465911 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | ![]() |
![]() |
2 | 4 | ||||||
MIRT465992 | TMEM189 | transmembrane protein 189 | ![]() |
![]() |
2 | 4 | ||||||
MIRT466302 | TIMM22 | translocase of inner mitochondrial membrane 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466575 | TBC1D2B | TBC1 domain family member 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT470558 | POU2F1 | POU class 2 homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471333 | PERP | PERP, TP53 apoptosis effector | ![]() |
![]() |
2 | 2 | ||||||
MIRT471659 | PALM2 | paralemmin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472363 | TSPAN1 | tetraspanin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT473468 | MCFD2 | multiple coagulation factor deficiency 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474702 | KIF3A | kinesin family member 3A | ![]() |
![]() |
2 | 2 | ||||||
MIRT476067 | GRIN2A | glutamate ionotropic receptor NMDA type subunit 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT476077 | GRB2 | growth factor receptor bound protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT476423 | GBA2 | glucosylceramidase beta 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT476463 | GATAD2B | GATA zinc finger domain containing 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT477877 | DYNLL2 | dynein light chain LC8-type 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478240 | DDX3X | DEAD-box helicase 3, X-linked | ![]() |
![]() |
2 | 4 | ||||||
MIRT479460 | CDK6 | cyclin dependent kinase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT481030 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT491496 | HLA-DOA | major histocompatibility complex, class II, DO alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT497585 | SLC23A1 | solute carrier family 23 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT498542 | TMEM30B | transmembrane protein 30B | ![]() |
![]() |
2 | 2 | ||||||
MIRT499263 | NBPF11 | NBPF member 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT504698 | ZNF117 | zinc finger protein 117 | ![]() |
![]() |
2 | 2 | ||||||
MIRT511288 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 4 | ||||||
MIRT523121 | HSP90B1 | heat shock protein 90 beta family member 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT529601 | H1F0 | H1 histone family member 0 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533481 | TRIM71 | tripartite motif containing 71 | ![]() |
![]() |
2 | 2 | ||||||
MIRT535571 | NUP37 | nucleoporin 37 | ![]() |
![]() |
2 | 4 | ||||||
MIRT537869 | EDA2R | ectodysplasin A2 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT538010 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT552681 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | ![]() |
![]() |
2 | 4 | ||||||
MIRT554986 | RAB39B | RAB39B, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT556659 | KMT2D | lysine methyltransferase 2D | ![]() |
![]() |
2 | 4 | ||||||
MIRT557437 | GTPBP2 | GTP binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560813 | CRTAP | cartilage associated protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT562115 | IGFBP5 | insulin like growth factor binding protein 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563103 | IFRD2 | interferon related developmental regulator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574199 | LMNB1 | lamin B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT623920 | FMNL3 | formin like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626551 | NMNAT2 | nicotinamide nucleotide adenylyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT645458 | ANKS6 | ankyrin repeat and sterile alpha motif domain containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT649082 | CACNA1B | calcium voltage-gated channel subunit alpha1 B | ![]() |
![]() |
2 | 2 | ||||||
MIRT659477 | CLDN1 | claudin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT667950 | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT701981 | MIER3 | MIER family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708694 | TFDP2 | transcription factor Dp-2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT709649 | DFFB | DNA fragmentation factor subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT710090 | FAM229B | family with sequence similarity 229 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT718396 | ALDH1A3 | aldehyde dehydrogenase 1 family member A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724972 | TNS1 | tensin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT756050 | HRH4 | histamine receptor H4 | 2 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|